The TLR3 monoclonal antibody CNTO3157 reduces rhinovirus-induced airway hyperresponsiveness in healthy subjects; however, it shows limited efficacy in improving symptoms in patients with COPD (no. NCT01704040) (234). The gene discussed is TLR3; the disease is airway hyperresponsiveness.